204 related articles for article (PubMed ID: 27528092)
1. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
2. Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.
Wu CS; Wei KL; Chou JL; Lu CK; Hsieh CC; Lin JM; Deng YF; Hsu WT; Wang HM; Leung CH; Ma DL; Li C; Chan MW
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598141
[TBL] [Abstract][Full Text] [Related]
3. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
Wei KL; Chou JL; Chen YC; Jin H; Chuang YM; Wu CS; Chan MWY
PLoS One; 2019; 14(6):e0218338. PubMed ID: 31194837
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer.
Wei KL; Chou JL; Chen YC; Low JT; Lin GL; Liu JL; Chang TS; Chen WM; Hsieh YY; Yan PS; Chuang YM; Lin JMJ; Wu SF; Chiang MK; Li C; Wu CS; Chan MWY
Front Oncol; 2021; 11():575667. PubMed ID: 33718136
[TBL] [Abstract][Full Text] [Related]
7. Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.
Shimizu R; Muto T; Aoyama K; Choi K; Takeuchi M; Koide S; Hasegawa N; Isshiki Y; Togasaki E; Kawajiri-Manako C; Nagao Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Iseki T; Starczynowski DT; Iwama A; Yokote K; Nakaseko C
Leuk Res; 2016 Nov; 50():85-94. PubMed ID: 27697661
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.
Souma Y; Nishida T; Serada S; Iwahori K; Takahashi T; Fujimoto M; Ripley B; Nakajima K; Miyazaki Y; Mori M; Doki Y; Sawa Y; Naka T
Int J Cancer; 2012 Sep; 131(6):1287-96. PubMed ID: 22095154
[TBL] [Abstract][Full Text] [Related]
10. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
Wang HC; Chen CW; Yang CL; Tsai IM; Hou YC; Chen CJ; Shan YS
Cancer Immunol Res; 2017 Oct; 5(10):885-897. PubMed ID: 28835422
[TBL] [Abstract][Full Text] [Related]
12. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
14. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development.
Yang W; Mok MT; Li MS; Kang W; Wang H; Chan AW; Chou JL; Chen J; Ng EK; To KF; Yu J; Chan MW; Chan FK; Sung JJ; Cheng AS
Oncogene; 2016 Apr; 35(16):2133-44. PubMed ID: 26212015
[TBL] [Abstract][Full Text] [Related]
17. Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers.
Tran MTMT; Yeh KT; Chuang YM; Hsu PY; Low JT; Kumari H; Lee YT; Chen YC; Huang WH; Jin H; Lin SH; Chan MWY
PLoS One; 2021; 16(4):e0250499. PubMed ID: 33886682
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
19. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
20. Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon.
Uekusa S; Kawashima H; Sugito K; Yoshizawa S; Shinojima Y; Igarashi J; Ghosh S; Wang X; Fujiwara K; Ikeda T; Koshinaga T; Soma M; Nagase H
Int J Oncol; 2014 May; 44(5):1669-77. PubMed ID: 24626568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
